Evolve BioPep
B2CPublishes source-linked benchmark inputs with external third-party record links and aggregated test/review coverage (Finnrick and Peptide Critic) on its vendor profile page.
- Based in
- United States
Profile aggregated from Peptigrity — attributed.
AGreat
peptideone Score · 9/10
Composite of 1 independent source
Purity 9/10
Weighted blend of independent signals — Finnrick safety grade, VialAudit blind-buy audit, and Peptigrity HPLC purity. PeptideBenchmark and the Peptigrity trust score are excluded to avoid double-counting. Attributed to its sources — not our verdict.
Independent test grades (0)
Per Finnrick (independent testing). Attributed — Finnrick's grades, not ours.
| Peptide | Grade | Score |
|---|
Independent HPLC tests (34)
Real third-party HPLC results for this vendor, aggregated from Peptigrity and attributed to the lab that ran each test.
| Peptide | HPLC purity | Lab | Date |
|---|---|---|---|
| CJC-1295 | 99.24% | Vanguard Laboratory | — |
| Tirzepatide | 99.00% | Ethos Analytics | 2026-05-21 |
| Ipamorelin | 99.00% | Ethos Analytics | 2026-05-21 |
| Cagrilintide | 99.00% | Ethos Analytics | 2026-04-25 |
| Retatrutide | 98.00% | Ethos Analytics | 2026-04-12 |
| N-Acetyl Semax |